Post-approval studies (Phase 4)Ended earlyNCT03389893
What this trial is testing
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 72